enVVeno Medical 

$11.24
25
-$0.23-1.99% Thursday 20:00
+$0.33+2.94%Thursday 20:00After hours

Statistics

Day High
11.24
Day Low
11.24
52W High
35.7
52W Low
8.67
Volume
5
Avg. Volume
-
Mkt Cap
7.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-10.5
-7.07
-3.65
-0.22
Expected EPS
-3.27
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-19.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVNO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap119.49B
Medtronic is a major player in the medical devices sector, offering products that can compete directly with enVVeno Medical's neurovascular and cardiovascular solutions.
Boston Scientific
BSX
Mkt Cap73B
Boston Scientific competes in the medical devices market, particularly in areas overlapping with enVVeno Medical's focus on neurovascular treatments.
Abbott Laboratories
ABT
Mkt Cap201.83B
Abbott Laboratories offers a wide range of medical devices, including those for cardiovascular and neuromodulation, making it a direct competitor.
Smith & Nephew
SNN
Mkt Cap12.25B
Smith & Nephew operates in the medical technology field, with products that could compete in the surgical sectors where enVVeno Medical may be involved.
Stryker
SYK
Mkt Cap126.37B
Stryker is known for its medical devices and equipment, competing in the neurotechnology and spine sector, which may overlap with enVVeno Medical's offerings.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those that could be in direct competition with enVVeno Medical.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which could include products and technologies competitive with enVVeno Medical's.
Edwards Lifesciences
EW
Mkt Cap51.75B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, areas that could see overlap with enVVeno Medical's cardiovascular solutions.
Intuitive Surgical
ISRG
Mkt Cap133.83B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the innovative surgical solutions space, potentially overlapping with enVVeno Medical's market.
Integra Lifesciences
IART
Mkt Cap1.3B
Integra LifeSciences, a provider of regenerative technologies, neurosurgical, and extremity orthopedic solutions, competes in areas that may overlap with enVVeno Medical's focus.

About

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Show more...
CEO
Robert A. Berman
Employees
33
Country
United States
ISIN
US29415J2050
WKN
000A42085

Listings

0 Comments

Share your thoughts

FAQ

What is enVVeno Medical stock price today?
The current price of NVNO is $11.24 USD — it has decreased by -1.99% in the past 24 hours. Watch enVVeno Medical stock price performance more closely on the chart.
What is enVVeno Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange enVVeno Medical stocks are traded under the ticker NVNO.
Is enVVeno Medical stock price growing?
NVNO stock has risen by +9.23% compared to the previous week, the month change is a +8.08% rise, over the last year enVVeno Medical has showed a -63.1% decrease.
What is enVVeno Medical market cap?
Today enVVeno Medical has the market capitalization of 7.81M
When is the next enVVeno Medical earnings date?
enVVeno Medical is going to release the next earnings report on November 05, 2026.
What were enVVeno Medical earnings last quarter?
NVNO earnings for the last quarter are -5.37 USD per share, whereas the estimation was -4.69 USD resulting in a -14.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is enVVeno Medical revenue for the last year?
enVVeno Medical revenue for the last year amounts to 0 USD.
What is enVVeno Medical net income for the last year?
NVNO net income for the last year is -19.47M USD.
How many employees does enVVeno Medical have?
As of August 28, 2026, the company has 33 employees.
In which sector is enVVeno Medical located?
enVVeno Medical operates in the Health & Wellness sector.
When did enVVeno Medical complete a stock split?
The last stock split for enVVeno Medical was on January 20, 2026 with a ratio of 1:35.
Where is enVVeno Medical headquartered?
enVVeno Medical is headquartered in IRVINE, United States.